A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Arteriovenous malformation - pulmonary
A small number of patients who have no symptoms may not need treatment. For most patients with fistulas, the treatment of choice is to block the fistula during an arteriogram (embolization).
Some patients may need surgery to remove the abnormal vessels and nearby lung tissue.
When arteriovenous fistulas are caused by liver disease, the treatment is a liver transplant.
The outlook for patients with HHT is not as good as for those without HHT. For patients with HHT, surgery to remove the abnormal vessels usually has a good outcome, and the condition is not likely to return.
Major complications after treatment for this condition are unusual. Complications may include:
Call your health care provider if you often have nosebleeds or difficulty breathing, especially if you also have a history of HHT.
Marelli AJ. Congenital heart disease in adults. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier;2007:chap 68.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.800.492.5538